CDC Budget, Funding Sources, and Appropriations

The Centers for Disease Control and Prevention operates on a multi-layered funding architecture that shapes every program it runs — from outbreak surveillance to chronic disease prevention. Congressional appropriations form the primary funding base, but user fees, emergency supplementals, and interagency transfers add significant complexity. Understanding how the CDC receives, classifies, and deploys funds is essential for grasping why certain programs persist through budget cycles while others are vulnerable to annual appropriations battles.

• Definition and scope
• Core mechanics or structure
• Causal relationships or drivers
• Classification boundaries
• Tradeoffs and tensions
• Common misconceptions
• Checklist or steps (non-advisory)
• Reference table or matrix

Definition and scope

The CDC's budget refers to the total congressionally authorized and appropriated funding made available to the agency in a given federal fiscal year (October 1 through September 30). This includes discretionary appropriations — which Congress sets annually through the Labor, Health and Human Services, Education, and Related Agencies (LHHS) appropriations bill — as well as mandatory spending streams, emergency supplemental appropriations, and transfers from the Department of Health and Human Services (HHS).

The agency's funding scope covers domestic public health programs, global health operations, laboratory infrastructure, epidemiological workforce, and grant-making activities distributed to state and local health departments. For fiscal year 2023, the President's budget request for CDC discretionary budget authority was approximately $9.8 billion (HHS FY2023 Congressional Justification), though final enacted amounts differ from requests after congressional negotiation.

Core mechanics or structure

CDC funding flows through three principal channels: annual discretionary appropriations, mandatory/trust fund accounts, and supplemental or emergency appropriations.

Annual discretionary appropriations constitute the agency's operating baseline. Congress allocates these funds through the LHHS appropriations subcommittee. The CDC Budget Request submitted by the President each February initiates this cycle, followed by committee markups, floor votes, and reconciliation between the House and Senate. Final enacted appropriations may differ substantially from the request — sometimes by hundreds of millions of dollars in either direction.

Mandatory and trust fund streams include the Prevention and Public Health Fund (PPHF), established under Section 4002 of the Affordable Care Act (Public Law 111-148). The PPHF is a mandatory appropriation that incrementally increases: the fund was set at $500 million for fiscal year 2010 and grows to a permanent annual level of $2 billion. A substantial share of PPHF resources flows to CDC for chronic disease prevention, immunization, epidemiology and laboratory capacity, and public health workforce development. The fund cannot be reprogrammed without congressional authorization, giving it structural stability that discretionary accounts lack.

Supplemental and emergency appropriations are enacted outside the regular appropriations cycle in response to declared emergencies. The COVID-19 pandemic triggered a series of emergency supplementals totaling more than $22 billion directed to CDC and related public health activities across 2020–2021, drawn from legislation including the Coronavirus Preparedness and Response Supplemental Appropriations Act (Public Law 116-123) and subsequent packages.

Interagency transfers and user fees supply additional resources. The CDC collects fees under the Export of Etiologic Agents authority and receives transfers from agencies such as the Department of Defense for infectious disease surveillance programs. These represent a smaller but operationally meaningful funding share.

The CDC and HHS relationship is structurally relevant here: the CDC operates as an operating division of HHS, meaning its budget justification is incorporated into the broader HHS budget submission, and reprogramming above certain thresholds requires HHS and sometimes congressional notification.

Causal relationships or drivers

Several factors directly influence the size and composition of CDC funding in any given fiscal year.

Disease events and declared emergencies create immediate upward pressure on supplemental appropriations. The 2014–2016 West Africa Ebola outbreak prompted Congress to pass a $5.4 billion emergency supplemental (Public Law 113-235), a meaningful portion of which supported CDC emergency response operations. Similarly, Zika preparedness in 2016 generated a $1.1 billion supplemental (Public Law 114-223).

Partisan budget cycles and discretionary caps create downward pressure. Under the Budget Control Act of 2011 (Public Law 112-25), discretionary spending limits constrained growth across all non-defense domestic agencies, including CDC, for a decade following enactment.

Earmarks and program-specific congressional mandates shape internal allocation. Congress frequently directs specific dollar amounts to named programs — such as the National Breast and Cervical Cancer Early Detection Program or the National Violent Death Reporting System — leaving CDC program managers limited flexibility to redirect funds based on emerging priorities.

State and local partnerships multiply the effective reach of CDC dollars. The agency passes a substantial share of appropriated funds through cooperative agreements and grants to state health departments, meaning the CDC's budget authority ultimately funds a distributed network of public health capacity rather than exclusively federal operations.

Classification boundaries

CDC appropriations fall into distinct legal and administrative categories that determine how funds may be used, transferred, and carried over:

• Budget authority vs. outlays: Budget authority is the legal permission to incur obligations; outlays are the actual cash disbursements. These differ in timing, particularly for multi-year grants.
• No-year vs. annual vs. multi-year funds: Emergency supplemental appropriations are frequently designated "no-year," meaning unexpended balances do not expire at fiscal year end. Standard discretionary appropriations are annual unless otherwise specified.
• Program project grants (PPGs) vs. cooperative agreements: Both are mechanisms for distributing funds externally, but cooperative agreements involve substantial federal programmatic involvement, while grants carry fewer federal performance conditions. The distinction affects reporting requirements and federal oversight intensity.
• Direct vs. reimbursable obligations: Reimbursable work occurs when CDC provides services to another federal agency and bills for the cost, generating authority that is not part of the original appropriation.

Tradeoffs and tensions

The CDC's funding structure creates durable tensions between competing institutional priorities.

Flexibility vs. congressional control: Program-directed appropriations and earmarks reduce CDC's ability to redirect resources when public health threats shift. When West Nile virus, novel influenza strains, or emerging respiratory pathogens require rapid reallocation, rigid line-item appropriations constrain the agency's operational response speed.

Emergency surge vs. baseline capacity: Heavy reliance on emergency supplementals means CDC budget authority can spike dramatically in crisis years then contract sharply when the emergency designation lapses. This volatility makes long-term workforce planning and infrastructure investment difficult — a pattern documented in CDC congressional oversight hearings following both the 2009 H1N1 response and the COVID-19 pandemic.

Domestic priorities vs. global health obligations: Appropriated funds designated for domestic programs cannot legally be redirected to international operations. CDC's Global Disease Detection program and PEPFAR-linked activities are funded through separate appropriations or interagency transfers, creating a structural separation between domestic public health emergency response and global health operations.

Prevention vs. response investment: The Prevention and Public Health Fund was specifically designed to shift the funding balance toward upstream prevention — chronic disease programs, immunization infrastructure, and epidemiological capacity. Appropriations riders that redirect PPHF dollars to other priorities undercut this structural intent.

Common misconceptions

Misconception: CDC sets its own budget.
The agency submits a budget request to HHS and the Office of Management and Budget (OMB), but Congress holds sole appropriations authority under Article I of the U.S. Constitution. Final enacted amounts frequently differ from requests by 10–30%.

Misconception: All CDC funding comes directly from Congress.
While the majority of CDC budget authority originates from congressional appropriations, the Prevention and Public Health Fund is a mandatory stream established by statute — its annual allocations do not require annual appropriations action and are not subject to the discretionary spending caps that govern most of the federal budget.

Misconception: Unspent CDC funds return to the Treasury at year-end.
Annual funds that are obligated (committed to a contract or grant) by September 30 remain available for outlay in subsequent years. Only unobligated annual funds expire. No-year emergency funds carry over without limitation.

Misconception: CDC directly controls all funds it receives.
A large share of CDC budget authority is passed through to state and local partnerships and tribal health programs under grant and cooperative agreement authority. The CDC functions as a funding intermediary for a significant portion of its appropriated dollars.

For a broader orientation to how the agency's resources intersect with its statutory powers, the CDC Authority and Legal Powers page provides relevant context. Readers seeking an overview of the full scope of agency activity can start at cdcauthority.com.

Checklist or steps (non-advisory)

Key stages in the annual CDC appropriations cycle:

1. February — President's Budget Submission: The President transmits the annual budget request to Congress, including the HHS budget in brief and the CDC's detailed congressional justification documents.
2. Spring — House and Senate Subcommittee Hearings: The LHHS appropriations subcommittees in both chambers hold hearings; CDC leadership testifies and submits written justifications for requested funding levels.
3. Committee Markup: Subcommittees draft appropriations bills that may accept, reduce, or increase the President's request for specific CDC program lines.
4. Floor Votes and Reconciliation: Both chambers pass their respective versions; differences are resolved in conference or through informal negotiations.
5. Enactment or Continuing Resolution: If full-year appropriations are not enacted by October 1, a continuing resolution (CR) maintains prior-year funding levels, often precluding new program starts or expansions.
6. OMB Apportionment: Once enacted, OMB apportions funds to HHS, which then allocates to CDC operating divisions and programs on a quarterly basis.
7. Obligation: CDC program offices obligate funds to grantees, contractors, and internal operations before the relevant fiscal year deadline.
8. Audit and Reporting: CDC submits annual financial statements audited by HHS's Office of Inspector General; results inform congressional oversight and subsequent budget cycles.

Reference table or matrix

CDC Funding Source Comparison